I dette forsøg var herpes zoster- reaktivering mere almindelig hos patienter behandlet med Vc+M+P sammenlignet med M+P (henholdsvis 11% og 3%).
In this study, herpes zoster reactivation was more common in patients treated with Vc+M+P compared with M+P (11% vs 3% respectively).